403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Tenovi Cellular-Connected RPM Blood Pressure Monitor Earns Listing On Validated Device Listing (VDLTM)
(MENAFN- EIN Presswire)
![Tenovi Logo]()
The listing reinforces Tenovi's commitment to clinical accuracy and gives healthcare teams added confidence when selecting a blood pressure monitor for RPM programs.
Research shows that some home blood pressure monitors can be inaccurate by 10% to 72% compared to mercury sphygmomanometers, depending on the device and model.1 Because of this wide variability, only a limited number of devices in the U.S. have been independently validated for clinical use.
“Earning a designation on the Validated Device Listing is a rigorous process, and we're proud to offer our clients and partners a clinically validated RPM blood pressure monitor for added trust,” said Nizan Friedman, Ph.D., Founder and CEO of Tenovi.“This milestone reinforces our commitment to accuracy and reliability in patient care.”
About Tenovi
Tenovi is a data aggregation and automation Healthcare IoT platform that connects remote medical device data with clinical care teams. It provides over 40 remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) device point solutions that integrate with its proprietary Cellular Gateway, automating the transfer of patient vitals. Tenovi's API-driven fulfillment and automation services enable seamless deployment of remote patient and therapeutic monitoring programs. Tenovi ranks No. 55 nationwide on the 2025 Inc. 5000 list of the fastest-growing private companies in America, No. 11 in healthcare, No. 1 in New Hampshire, and No. 2 in Boston. For more information, visit .
1Hiremath, Swapnil & Sterling, Brayden & Glassman, Isaac & Ruzicka, Marcel. (2024). Abstract P317: Are Home Blood Pressure Devices Accurate? A Systematic Review of the Evidence. Hypertension. 81. 81_1.P317.
Tenovi's Cellular-Connected BP Monitor listed on validatebp after meeting rigorous clinical accuracy standards
PORTSMOUTH, NH, UNITED STATES, September 16, 2025 /EINPresswire / -- Tenovi , a leading provider of remote monitoring solutions, today announced that the cellular-connected Tenovi Blood Pressure Monitor models (TC-BPM-L2, TC-BPM-S2, and TC-BPM-A2 / TC-BPM-M2) meet the Validated Device Listing (“VDL”) criteria (as listed on validatebp ) for validation of clinical accuracy, based on the independent review and acceptance of documentation submitted by the manufacturer.The listing reinforces Tenovi's commitment to clinical accuracy and gives healthcare teams added confidence when selecting a blood pressure monitor for RPM programs.
Research shows that some home blood pressure monitors can be inaccurate by 10% to 72% compared to mercury sphygmomanometers, depending on the device and model.1 Because of this wide variability, only a limited number of devices in the U.S. have been independently validated for clinical use.
“Earning a designation on the Validated Device Listing is a rigorous process, and we're proud to offer our clients and partners a clinically validated RPM blood pressure monitor for added trust,” said Nizan Friedman, Ph.D., Founder and CEO of Tenovi.“This milestone reinforces our commitment to accuracy and reliability in patient care.”
About Tenovi
Tenovi is a data aggregation and automation Healthcare IoT platform that connects remote medical device data with clinical care teams. It provides over 40 remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) device point solutions that integrate with its proprietary Cellular Gateway, automating the transfer of patient vitals. Tenovi's API-driven fulfillment and automation services enable seamless deployment of remote patient and therapeutic monitoring programs. Tenovi ranks No. 55 nationwide on the 2025 Inc. 5000 list of the fastest-growing private companies in America, No. 11 in healthcare, No. 1 in New Hampshire, and No. 2 in Boston. For more information, visit .
1Hiremath, Swapnil & Sterling, Brayden & Glassman, Isaac & Ruzicka, Marcel. (2024). Abstract P317: Are Home Blood Pressure Devices Accurate? A Systematic Review of the Evidence. Hypertension. 81. 81_1.P317.
Media Relations
Tenovi
+1 714-418-5658
...
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Thinkmarkets Adds Synthetic Indices To Its Product Offering
- T-REX Launches Intelligence Layer To Fix Web3's Value Distribution Problem
- BTCC Exchange Maintains 143% Total Reserve Ratio In September 2025 Demonstrating Continued Financial Strength
- Ethereum-Based Defi Crypto Mutuum Finance (MUTM) Raises Over $16 Million With More Than 720M Tokens Sold
- Superiorstar Prosperity Group Russell Hawthorne Highlights New Machine Learning Risk Framework
- R0AR Chain Announces $100,000 Community Rewards For Creators, Yappers, And Brand Evangelists
More Story
Comments
No comment